v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (4,063) $ (4,753)
Adjustments to reconcile net loss to net cash used in operating activities:    
Loss on debt extinguishment, net 1,840
Unrealized foreign exchange gain (1) (26)
Change in fair value of convertible notes payable 290 (274)
Gain on change in fair value of derivative warrant liability (130)
Loss on equity method investment 68
Gain on waiver of accrued interest (371)
Stock-based compensation expense 198 234
Non-cash interest expense 79 167
Operating lease obligations 29
Depreciation expense 7 5
Amortization of financed directors and officers insurance 311 369
Issuance of common stock for services 530
Amortization expense 542 192
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (787) (255)
Accounts payable 532 (721)
Accrued expenses and other liabilities 434 (207)
Lease liability (34) (28)
Net cash flows used in operating activities (1,894) (3,929)
Cash flows from investing activities:    
Purchases of equipment and clinical assets (404)
Net cash flows used in investing activities (404)
Cash flows from financing activities:    
Net proceeds from the issuance of notes payable 487
Proceeds from issuance of common shares related to the ATM program 8,061
Repayment of notes payable – related parties (425)
Repayment of notes payable (151)
Repayment of convertible notes payable – related parties (927)
Repayment of convertible notes payable (631)
Net cash flows provided by financing activities 487 5,927
Net change in cash and cash equivalents before effect of exchange rate changes (1,407) 1,594
Effect of exchange rate changes on cash and cash equivalents (5) (18)
Net change in cash (1,412) 1,576
Cash and cash equivalents at beginning of period 1,509 554
Cash and cash equivalents at end of period 97 2,130
Supplemental cash flow information:    
Cash paid for interest 170
Cash paid for taxes
Non-cash investing and financing activities    
Issuance of common stock upon exercise of conversion option 709 4,077
Issuance of common stock for investment in related party 622
Deferred cash payable for investment in related party 8,000
Issuance of pre-funded warrants for investment in related party $ 114,378